Delivery Order SPE2D020D0009-SPE2D324F287F

Award Date 9/24/24
Potential Completion Date 9/27/24
Potential Value $3.3K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lake Zurich, IL, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, SPE2D020D0009|SPE2D324F286Z, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense agency, to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The $110,176.15 firm fixed-price delivery order is for the supply of Doxycycline Hydrochloride Injection (10), a critical care pharmaceutical, with a completion date of September 27, 2024. Fresenius Kabi, LLC is a major supplier of injectable...
This federal contract award, SPE2D020D0009|SPE2D321F126S, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is for the delivery of Doxycycline Hydrochloride Injection, a critical care pharmaceutical, with a total ceiling value of $87,387.10. The contract is structured as a Firm Fixed Price Delivery Order and does not have a set-aside designation....
This is a $2,393.12 firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 60 ml of 25 mg/5 ml doxycycline suspension and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,875,575 units of Doxycycline Hyclate 100 mg tablets. The contract has a ceiling value of $4,147.32 and a period of performance through April 11, 2025. It is a firm-fixed price delivery order contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $1,712.70, is for the delivery of doxycycline hyclate, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to issue firm fixed-price delivery orders...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of $1,370.16 worth of doxycycline hyclate, a prescription medication. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, which allows the agency to issue delivery orders for a comprehensive range of...
This is a $106,618.56 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of 4,537,254 units of 100 mg doxycycline capsules, a generic antibiotic medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA to provide a comprehensive range of pharmaceutical products...
This federal contract award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by the prime contractor, Amerisourcebergen Drug Corp, with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999, is the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense and other federal healthcare programs. The specific delivery order awarded is for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,303.57 firm fixed-price contract is for the delivery of 4,555,299,540 units of doxycycline hyclate 100 mg tablets. The contract is not designated as a set-aside and was awarded on an unrestricted, full and open competitive basis. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support...
This is a $3,107.22 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 4,567,751,304 units of 50 mg doxycycline tablets, a generic antibiotic medication, with a period of performance through April 1, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
  • SPE2D020D0009
    Indefinite Delivery Contract
  • SPE2D020D0009-SPE2D324F287F
    Delivery Order

This is a delivery order contract awarded to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract is for the supply of doxycycline hydrochloride injection (10) at a ceiling value of $3,333.06. The contract has a firm fixed price pricing type and an ultimate completion date of September 27, 2024. This delivery order is not set aside and is part of Fresenius Kabi's broader indefinite delivery contract (IDC) with the Department of Veterans Affairs National Acquisition Center, valued at $2.24 million, for the supply of bortezomib, a cancer treatment drug. The award demonstrates Fresenius Kabi's capability to consistently manufacture and supply a diverse array of essential medications to support military and federal healthcare operations.

Generated 12/24/24, 9:31 AM